GTHX - G1 Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GTHX is currently covered by 5 analysts with an average price target of $19.28. This is a potential upside of $12.13 (169.65%) from yesterday's end of day stock price of $7.15.

G1 Therapeutics's activity chart (see below) currently has 41 price targets and 56 ratings on display. The stock rating distribution of GTHX is 93.1% BUY, 3.45% HOLD and 3.45% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25.87% with an average time for these price targets to be met of 97.67 days.

Highest price target for GTHX is $4, Lowest price target is $3, average price target is $19.28.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 07-Aug-2024. First documented stock forecast 12-Jun-2017.

Best performing analysts who are covering GTHX - G1 Therapeutics:

Chad Messer David Nierengarten Anupam Rama Dane Leone Gil Blum Edward White

Currently out of the existing stock ratings of GTHX, 27 are a BUY (93.1%), 1 are a HOLD (3.45%), 1 are a SELL (3.45%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$6

3 months 13 days ago
(07-Aug-2024)

1/9 (11.11%)

$3.8 (172.73%)

43

Buy

$3

$-4.15 (-58.04%)

$9

4 months 26 days ago
(25-Jun-2024)

1/11 (9.09%)

$0.8 (36.36%)

17

Buy

$4

$-3.15 (-44.06%)

$5

9 months 7 days ago
(13-Feb-2024)

4/8 (50%)

$1.9 (90.48%)

189

Sell

$10

1 years 1 months 14 days ago
(06-Oct-2023)

1/5 (20%)

$2.57 (34.59%)

86

Buy

$24

$16.85 (235.66%)

2 years 6 months 25 days ago
(26-Apr-2022)

1/4 (25%)

$18.07 (304.72%)

63

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GTHX (G1 Therapeutics) average time for price targets to be met?

On average it took 97.67 days on average for the stock forecasts to be realized with a an average price target met ratio 25.87

Which analyst has the current highest performing score on GTHX (G1 Therapeutics) with a proven track record?

CHAD MESSER

Which analyst has the current lower performing score on GTHX (G1 Therapeutics) with a proven track record?

EDWARD WHITE

Which analyst has the most public recommendations on GTHX (G1 Therapeutics)?

Chad Messer has 6 price targets and 8 ratings on GTHX

Which analyst is the currently most bullish on GTHX (G1 Therapeutics)?

Chad Messer with highest potential upside - $60.85

Which analyst is the currently most reserved on GTHX (G1 Therapeutics)?

Edward White with lowest potential downside - -$4.15

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?